Suppr超能文献

多西环素经皮治疗近关节处动脉瘤样骨囊肿

Percutaneous Doxycycline Treatment of Juxtaphyseal Aneurysmal Bone Cysts.

作者信息

Shiels William E, Beebe Allan C, Mayerson Joel L

机构信息

Departments of *Radiology †Orthopedic Surgery, Nationwide Children's Hospital and The Ohio State University Medical Center, Columbus, OH.

出版信息

J Pediatr Orthop. 2016 Mar;36(2):205-12. doi: 10.1097/BPO.0000000000000413.

Abstract

BACKGROUND

A recurrence rate of 19% to 23% has been reported in juxtaphyseal aneurysmal bone cysts (ABC) without en bloc resection or amputation. No percutaneous surgical techniques or drug treatments have demonstrated consistent bone healing with normal physeal growth and a recurrence rate of <19%. Doxycycline has properties that may make it an appropriate agent for percutaneous treatment of juxtaphyseal ABC in skeletally immature patients.

METHODS

We retrospectively reviewed 16 patients who underwent percutaneous treatment of ABCs with doxycycline from 2006 to 2011. The mean age was 7.1 years (range, 2 to 15 y). There were 16 treatment locations: humerus (9), tibia (3), fibula (2), femur (1), and ulna (1). Sixteen patients completed treatment involving 102 treatment sessions (2 to 14 sessions per patient). Treatment response was evaluated radiographically by measuring the lytic component, thickness of involved cortex, and signs of bony remodeling, and evidence of physeal growth arrest. Recurrence was indicated by new areas of lytic destruction after completion of treatment. The minimum follow-up was 18 months (mean, 39 mo).

RESULTS

All 16 patients demonstrated reduction in lytic destruction, bony healing, and bony remodeling. One patient demonstrated recurrent minimal lytic destruction after 20 months of observation. Seven patients (7/16, 44%) demonstrated physeal ABC involvement; 5 of 7 patients healed with a physeal bone bridge, all ≤15% of the physeal surface area, 1 with mild central physeal deformity. All patients with focal transphyseal ABC involvement (4/4, 100%) demonstrated focal bone bridge after treatment. No patient had diffuse physeal growth arrest; only patients with intraphyseal or transphyseal ABC involvement had focal physeal growth arrest.

CONCLUSIONS

In this series, patients undergoing percutaneous doxycycline treatment of juxtaphyseal ABCs demonstrated ABC healing and a recurrence rate of 6% at >18 months. Patients without physeal ABC involvement demonstrated no evidence of physeal growth arrest.

摘要

背景

据报道,未进行整块切除或截肢的干骺端动脉瘤样骨囊肿(ABC)复发率为19%至23%。尚无经皮手术技术或药物治疗能持续实现骨愈合且骨骺正常生长,复发率低于19%。强力霉素具有的特性可能使其成为对骨骼未成熟患者经皮治疗干骺端ABC的合适药物。

方法

我们回顾性分析了2006年至2011年间接受强力霉素经皮治疗ABC的16例患者。平均年龄为7.1岁(范围2至15岁)。共有16个治疗部位:肱骨(9个)、胫骨(3个)、腓骨(2个)、股骨(1个)和尺骨(1个)。16例患者完成治疗,共进行102次治疗疗程(每位患者2至14次疗程)。通过测量溶骨成分、受累皮质厚度、骨重塑迹象以及骨骺生长停滞的证据,以影像学方式评估治疗反应。治疗完成后新出现的溶骨性破坏区域提示复发。最短随访时间为18个月(平均39个月)。

结果

所有16例患者均表现出溶骨破坏减轻、骨愈合和骨重塑。1例患者在观察20个月后出现复发性轻微溶骨破坏。7例患者(7/16,44%)的骨骺受ABC累及;7例患者中有5例通过骨骺骨桥愈合,所有骨桥面积均≤骨骺表面积的15%,1例伴有轻度中央骨骺畸形。所有局灶性经骨骺ABC累及的患者(4/4,100%)治疗后均出现局灶性骨桥。无患者出现弥漫性骨骺生长停滞;仅骨骺内或经骨骺ABC累及的患者出现局灶性骨骺生长停滞。

结论

在本系列研究中,接受强力霉素经皮治疗干骺端ABC的患者显示ABC愈合,18个月以上的复发率为6%。未累及骨骺ABC的患者未出现骨骺生长停滞的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验